The invention provides a method of treating a mammal having, or at risk of, an indication associated with a TGF-beta deficiency comprising administering one or more agents that is effective to elevate the level of TGF-beta. The invention also provides novel compounds that elevate TGF-beta levels, as well as pharmaceutical compositions comprising compounds that elevate TGF-beta levels, and methods for detecting diseases associated with endothelial cell activation.

 
Web www.patentalert.com

< Methods of using an agonistic antibody human tumor necrosis factor receptor (TR17)

< Nucleic acids encoding tumor necrosis factor receptor TR10

> Overlapping coated stents

> Pulsatile blood pumping system

~ 00278